Multiple myeloma

You are here: 

Consolidation therapy for multiple myeloma

Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.

Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).

Stories

Morgan Smith Even though we are high school students, we were able to raise so much money for the Canadian Cancer Society. It just goes to show what can happen when a small group of people come together for a great cause.

Read Morgan's story

A helping hand for families

Illustration of crowd

The Canadian Cancer Society helps with expenses for children in cancer treatment and their families.

Learn more